250 related articles for article (PubMed ID: 28721555)
1. The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study.
Collins JT; Noble S; Chester J; Davies HE; Evans WD; Farewell D; Lester JF; Parry D; Pettit R; Byrne A
Support Care Cancer; 2018 Jan; 26(1):119-127. PubMed ID: 28721555
[TBL] [Abstract][Full Text] [Related]
2. Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: an observational study protocol.
Collins JT; Noble S; Chester J; Davies HE; Evans WD; Lester J; Parry D; Pettit RJ; Byrne A
BMC Cancer; 2015 Jul; 15():544. PubMed ID: 26204885
[TBL] [Abstract][Full Text] [Related]
3. Performance status agreement assessed by the patient and clinician in a rapid access lung cancer service: Can either predict completion of treatment?
Collins JT; Noble S; Davies HE; Farewell D; Lester JF; Parry D; Byrne A
Eur J Cancer Care (Engl); 2019 May; 28(3):e13004. PubMed ID: 30761639
[TBL] [Abstract][Full Text] [Related]
4. Is the ECOG-PS similar to the sarcopenia status for predicting mortality in older adults with cancer? A prospective cohort study.
Sousa IM; Fayh APT
Support Care Cancer; 2023 Jun; 31(6):370. PubMed ID: 37266669
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic chemotherapy in advanced non-small cell lung cancer with poor performance status: A retrospective analysis from routine clinical practice.
Kancharla H; Gundu N; Pathak N; Vandidassane I; Khurana S; Pushpam D; Jain D; Kumar S; Pathy S; Mohan A; Malik PS
Curr Probl Cancer; 2020 Jun; 44(3):100550. PubMed ID: 31987521
[TBL] [Abstract][Full Text] [Related]
6. Do multidisciplinary team meetings make a difference in the management of lung cancer?
Boxer MM; Vinod SK; Shafiq J; Duggan KJ
Cancer; 2011 Nov; 117(22):5112-20. PubMed ID: 21523766
[TBL] [Abstract][Full Text] [Related]
7. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
8. Nutritional status and physical performance using handgrip and SPPB tests in hospitalized older adults.
Amasene M; Besga A; Medrano M; Urquiza M; Rodriguez-Larrad A; Tobalina I; Barroso J; Irazusta J; Labayen I
Clin Nutr; 2021 Nov; 40(11):5547-5555. PubMed ID: 34656951
[TBL] [Abstract][Full Text] [Related]
9. Relationship Between Preoperative Sarcopenia Status and Immuno-nutritional Parameters in Patients with Early-stage Non-small Cell Lung Cancer.
Shoji F; Matsubara T; Kozuma Y; Haratake N; Akamine T; Takamori S; Katsura M; Toyokawa G; Okamoto T; Maehara Y
Anticancer Res; 2017 Dec; 37(12):6997-7003. PubMed ID: 29187486
[TBL] [Abstract][Full Text] [Related]
10. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
[TBL] [Abstract][Full Text] [Related]
11. Surgical results of metastatic spinal cord compression (MSCC) from non-small cell lung cancer (NSCLC): analysis of functional outcome, survival time, and complication.
Park SJ; Lee CS; Chung SS
Spine J; 2016 Mar; 16(3):322-8. PubMed ID: 26586194
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic value of the Short Physical Performance Battery for sarcopenia.
Phu S; Kirk B; Bani Hassan E; Vogrin S; Zanker J; Bernardo S; Duque G
BMC Geriatr; 2020 Jul; 20(1):242. PubMed ID: 32660438
[TBL] [Abstract][Full Text] [Related]
13. Effects of a 2-year exercise training on neuromuscular system health in older individuals with low muscle function.
Monti E; Tagliaferri S; Zampieri S; Sarto F; Sirago G; Franchi MV; Ticinesi A; Longobucco Y; Adorni E; Lauretani F; Von Haehling S; Marzetti E; Calvani R; Bernabei R; Cesari M; Maggio M; Narici MV
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):794-804. PubMed ID: 36708273
[TBL] [Abstract][Full Text] [Related]
14. Association of Performance Status With Survival in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pembrolizumab Monotherapy.
Sehgal K; Gill RR; Widick P; Bindal P; McDonald DC; Shea M; Rangachari D; Costa DB
JAMA Netw Open; 2021 Feb; 4(2):e2037120. PubMed ID: 33570575
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
16. Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning.
Dong X; Dan X; Yawen A; Haibo X; Huan L; Mengqi T; Linglong C; Zhao R
Thorac Cancer; 2020 Sep; 11(9):2650-2659. PubMed ID: 32767522
[TBL] [Abstract][Full Text] [Related]
17. Outcomes to first-line pembrolizumab in patients with PD-L1-high (≥50%) non-small cell lung cancer and a poor performance status.
Alessi JV; Ricciuti B; Jiménez-Aguilar E; Hong F; Wei Z; Nishino M; Plodkowski AJ; Sawan P; Luo J; Rizvi H; Carter BW; Heymach JV; Altan M; Hellmann M; Awad M
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32753547
[TBL] [Abstract][Full Text] [Related]
18. Rapid atrophy of cardiac left ventricular mass in patients with non-small cell carcinoma of the lung.
Kazemi-Bajestani SMR; Becher H; Butts C; Basappa NS; Smylie M; Joy AA; Sangha R; Gallivan A; Kavsak P; Chu Q; Baracos VE
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1070-1082. PubMed ID: 31293070
[TBL] [Abstract][Full Text] [Related]
19. SPPB reference values and performance in assessing sarcopenia in community-dwelling Singaporeans - Yishun study.
Lee SY; Choo PL; Pang BWJ; Lau LK; Jabbar KA; Seah WT; Chen KK; Ng TP; Wee SL
BMC Geriatr; 2021 Mar; 21(1):213. PubMed ID: 33781211
[TBL] [Abstract][Full Text] [Related]
20. Early Skeletal Muscle Loss in Non-Small Cell Lung Cancer Patients Receiving Chemoradiation and Relationship to Survival.
Kiss N; Beraldo J; Everitt S
Support Care Cancer; 2019 Jul; 27(7):2657-2664. PubMed ID: 30478673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
